[Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].
E V
EV
Golovanova
S G
SG
Khomeriki
A V
AV
Petrakov
T I
TI
Serova
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D019819:Budesonide / Q000627:therapeutic use*; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019693:Hepatitis, Autoimmune / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D002756:Cholagogues and Choleretics; D019819:Budesonide; D014580:Ursodeoxycholic Acid